Особенности этиологии и патогенеза хронической сердечной недостаточности у пациентов старших возрастных групп
- Авторы: Яковлев А.А.1,2,3
-
Учреждения:
- Санкт-Петербургский институт биорегуляции и геронтологии
- Городская многопрофильная больница №2
- Санкт-Петербургский государственный университет
- Выпуск: Том 33, № 6 (2022)
- Страницы: 13-19
- Раздел: Актуальная тема
- URL: https://journals.eco-vector.com/0236-3054/article/view/114629
- DOI: https://doi.org/10.29296/25877305-2022-06-02
- ID: 114629
Цитировать
Полный текст
Открытый доступ
Доступ предоставлен
Доступ платный или только для подписчиков
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
В обзоре представлен анализ литературы по наиболее частым причинам развития хронической сердечной недостаточности в старших возрастных группах. Описаны особенности патогенеза заболевания в пожилом и старческом возрасте.
Полный текст
Об авторах
А. А. Яковлев
Санкт-Петербургский институт биорегуляции и геронтологии; Городская многопрофильная больница №2; Санкт-Петербургский государственный университет
Автор, ответственный за переписку.
Email: yakotema@yandex.ru
кандидат медицинских наук
Список литературы
- Tsao C.W., Lyass A., Enserro D. et al. Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction. JACC: Heart Fail. 2018; 6 (8): 678-85. doi: 10.1016/j.jchf.2018.03.006
- Виноградова Н.Г., Поляков Д.С., Фомин И.В. Анализ смертности у пациентов с ХСН после декомпенсации при длительном наблюдении в условиях специализированной медицинской помощи и в реальной клинической практике. Кардиология. 2020; 60 (4): 91-100. doi: 10.18087/cardio.2020.4.n1014
- Shah K.S., Xu H., Matsouaka R.A. Heart Failure with Preserved, Borderline, and Reduced Ejection Fraction. J. Am Coll Cardiol. 2017; 70 (20): 2476-86. doi: 10.1016/j.jacc.2017.08.074
- Smith W.M. Epidemiology of congestive heart failure. Am J. Cardiol. 1985; 55 (2): 3A-8A. doi: 10.1016/0002-9149(85)90789-1
- Gibson T.C., White K.L., Klainer L.M. The prevalence of congestive heart failure in two rural communities. J. Chronic Dis. 1966; 19 (2): 141-52. doi: 10.1016/0021-9681(66)90045-2
- Kalon K.L., Pinsky J.L., Kannel W.B. et al. The epidemiology of heart failure: Framingham Study. J. Am Coll Cardiol. 1993; 22 (4): 6A-13A. doi: 10.1016/0735-1097(93)90455-A
- Mahmood S.S., Wang T.J. The epidemiology of congestive heart failure: the Framingham Heart Study perspective. Global Heart. 2013; 8 (1): 77-82. DOI: 10.1016/j. gheart.2012.12.006
- Cybulska B., Klosiewicz-Latoszek L. Landmark studies in coronary heart disease epidemiology. The Framingham Heart Study after 70 years and the Seven Countries Study after 60 years. Kardiol Pol. 2019; 77 (2): 173-80. doi: 10.5603/KP.a2019.0017
- Ho K.K., Pinsky J.L., Kannel W.B. et al. The epidemiology of heart failure: Framingham Study. J. Am Coll Cardiol. 1993; 4: 6A-13A. doi: 10.1016/0735-1097(93)90455-a
- Sutton G.C. Epidemiologic aspects of heart failure. Am Heart J. 1990; 120 (6): 1538 40. doi: 10.1016/0002-8703(90)90055-3
- Sciomer S., Moscucci F., Salvioni E. et al. Role of gender, age and BMI in prognosis of heart failure. Eur J. Prev Cardiol. 2020; 27 (2): 46-51. doi: 10.1177/2047487320961980
- Swedberg K., Cleland J., Dargie H. et al. Diagnosis and treatment of chronic heart disease. Guidelines of the European Society of Cardiology. Revision 2005. Kardiol Pol. 2005; 63 (5): 509-43.
- Solal A.C., Tournoux F., Beauvais F. et al. Comment evaluer et traiter l'insuffisance cardiaque a fraction dejection preservee. Therapie. 2009; 64 (2): 101-9 (in French). doi: 10.2515/therapie/2009012
- Gobel S., Hobohm L., Ostad M.A. et al. Sex-specific differences drive temporal trends and outcomes of patients hospitalized for heart failure in Germany. Prog Cardiovasc Dis. 2020; 63 (5): 591-8. doi: 10.1016/j.pcad.2020.03.013
- Klein L., Grau-Sepulveda M.V., Bonow R.O. et al. Quality of care and outcomes in women hospitalized for heart failure. Circulation. Heart Fail. 2011; 4 (5): 589-98. doi: 10.1161/CIRCHEARTFAILURE.110.960484
- Scardovi A.B., Petruzzi M., Rosano A. et al. Heart failure phenotype in women. Giornale italiano di cardiologia (Rome). 2012; 13 (1): 6S-11S.
- Crousillat D.R., Ibrahim N.E. Sex Differences in the Management of Advanced Heart Failure. Curr Treat Options Cardiovasc Med. 2018; 20 (11): 88. doi: 10.1007/s11936-018-0687-y
- Нестеров В.С., Урванцева И.А., Воробьев А.С. Хроническая сердечная недостаточность: современные проблемы и пути их решения. Лечащий врач. 2018; 7: 11-4.
- Поляков Д.С., Фомин И.В., Беленков Ю.Н. и др. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА-ХСН. Кардиология. 2021; 61 (4): 4-14. doi: 10.18087/cardio.2021.4.n1628
- Ponikowski P., Voors A.A., Anker S.D. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37 (27): 2129-200. doi: 10.1093/eurheartj/ehw128
- Cubillos-Garzon L.A., Casas J.P., Morillo C.A. et al. Congestive heart failure in Latin America: the next epidemic. Am Heart J. 2004; 147 (3): 412-7. doi: 10.1016/j.ahj.2003.07.026
- Rohde L.E., Clausell N., Ribeiro J.P. et al. Health outcomes in decompensated congestive heart failure: a comparison of tertiary hospitals in Brazil and United. Int J. Cardiol. 2005; 102 (1): 71-7. doi: 10.1016/j.ijcard.2004.04.006
- Orso F., Fabbri G., Maggioni A.P. Epidemiology of Heart Failure. Handb Exp Pharmacol. 2017; 243: 15-33. doi: 10.1007/164_2016_74
- Spinar J., Spinarova L., Vitovec J. Pathophysiology, causes and epidemiology of chronic heart failure. VnitrLek. 2018; 64 (9): 834-8.
- Cook C., Cole G., Asaria P. et al. The annual global economic burden of heart failure. Int J. Cardiol. 2014; 171 (3): 368-76. doi: 10.1016/j.ijcard.2013.12.028
- Yingchoncharoen T., Wu T.C., Choi D.J. et al. Economic Burden of Heart Failure in Asian Countries with Different Healthcare Systems. Korean Circ J. 2021; 51 (8): 681-93. doi: 10.4070/kcj.2021.0029
- Johnson N.B., Hayes L.D., Brown K. et al. Centers for Disease Control and Prevention (CDC). CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors-United States, 2005-2013. MMWR Suppl. 2014; 63 (4): 3-27.
- Dharmarajan K., Rich M.W. Epidemiology, Pathophysiology, and Prognosis of Heart Failure in Older Adults. Heart Fail Clin. 2017; 13 (3): 417-26. doi: 10.1016/j.hfc.2017.02.001.
- Bories M.C., Bialobroda J., Bichara E. et al. Congestive heart failure in adults. Rev Prat. 2021; 71 (1): e3-e10. URL: https://www.researchgate.net/publication/352881365
- Бойцов С.А., Баланова Ю.А., Шальнова С.А. и др. Артериальная гипертония среди лиц 25-64 лет: распространенность, осведомленность, лечение и контроль по материалам исследования ЭССЕ. Кардиоваскулярная терапия и профилактика. 2014; 13 (4): 4-14. doi: 10.15829/1728-8800-2014-4-4-14
- Gerber Y., Weston S.A., Enriquez-Sarano M. et al. Mortality associated with heart failure after myocardial infarction: a contemporary community perspective. Circulation. Heart Fail. 2016; 9 (1): e002460-e002460. doi: 10.1161/circheartfailure.115.002460
- Xanthakis V., Enserro D.M., Larson M.G. et al. Prevalence, Neurohormonal Correlates, and Prognosis of Heart Failure Stages in the Community. JACC: Heart Fail. 2016; 4 (10): 808-15. doi: 10.1016/j.jchf.2016.05.001
- Benjamin E.J., Muntner P., Alonso A. et al. Heart Disease and Stroke Statistics-2019 Update: A Report from the American Heart Association. Circulation. 2019; 139 (10): e56-e528. doi: 10.1161/CIR.0000000000000659
- CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N. Engl J. Med. 1987; 316 (23): 1429-35. doi: 10.1056/NEJM198706043162301
- DeVore A.D., Thomas L., Albert N.M. et al. Change the management of patients with heart failure: Rationale and design of the CHAMP-HF registry. Am Heart J. 2017; 189: 177-83. doi: 10.1016/j.ahj.2017.04.010.
- Komajda M., Bohm M., Borer J.S. et al. Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis. Eur J. Heart Fail. 2018; 20 (9): 1315-22. doi: 10.1002/ejhf.1234
- Gelbrich G., Stork S., KreiBl-Kemmer S. et al. Effects of structured heart failure disease management on mortality and morbidity depend on patients' mood: results from the Interdisciplinary Network for Heart Failure Study: Effects of structured HF management depend on patients' mood. Eur J. Heart Fail. 2014; 16 (10): 1133-41. doi: 10.1002/ejhf.150
- Bragazzi N.L., Zhong W., Shu J. et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J. Prev Cardiol. 2021; 28 (15): 1682-90. doi: 10.1093/eurjpc/zwaa147
- Фомин И.В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать. Российский кардиологический журнал. 2016; 8: 7-13. doi: 10.15829/1560-4071-2016-8-7-13
- Yancy C.W., Jessup M., Bozkurt B. et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 AC-CF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017; 136 (6): e137-e161. doi: 10.1161/CIR.0000000000000509
- Groenewegen A., Rutten F.H., Mosterd A. et al. Epidemiology of heart failure. Eur J. Heart Fail. 2020; 22 (8): 1342-56. doi: 10.1002/ejhf.1858
- Di Tano G., De Maria R., Gonzini L. et al. The 30-day metric in acute heart failure revisited: data from IN-HF Outcome, an Italian nationwide cardiology registry. Eur J. Heart Fail. 2015; 17 (10): 1032-41. doi: 10.1002/ejhf.290
- Taylor C.J., Ordonez-Mena J.M., Roalfe A.K. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study. BMJ. 2016; 364: l223. doi: 10.1136/bmj.l223
- Berthelot E., Nouhaud C., Lafuente-Lafuente C. et al. Heart failure in patients over 80 years old. Presse Med. 2019; 48 (2): 143-53. doi: 10.1016/j.lpm.2019.02.001
- Pagel P.S., Tawil J.N., Boettcher B.T. et al. Heart Failure With Preserved Ejection Fraction: A Comprehensive Review and Update of Diagnosis, Pathophysiology, Treatment, and Perioperative Implications. J. Cardiothorac Vasc Anestha. 2021; 35 (6): 1839-59. doi: 10.1053/j.jvca.2020.07.016
- Truby L.K., Rogers J.G. Advanced Heart Failure: Epidemiology, Diagnosis, and Therapeutic Approaches. JACC. Heart Fail. 2020; 8 (7): 523-36. doi: 10.1016/j.jchf.2020.01.014
- Chaudhry S.P., Stewart G.C. Advanced Heart Failure: Prevalence, Natural History, and Prognosis. Heart Fail Clin. 2016; 12 (3): 323-33. doi: 10.1016/j.hfc.2016.03.001
- Терещенко С.Н., Жиров И.В., Нарусов О.Ю. и др. Диагностика и лечение хронической и острой сердечной недостаточности. Кардиологический вестник. 2016; 2: 3-33.
- Makowska A.M., Jorstad H.T., van den Brink R.B.A. et al. Dyspnoea. Ned Tijdschr Geneeskd. 2020; 164: D3658.
- Olivieri F., Recchioni R., Marcheselli F. et al. Cellular senescence in cardiovascular diseases: potential age-related mechanisms and implications for treatment. Curr Pharm Des. 2013; 19 (9): 1710-9.
- Dong M., Yang Z., Fang F. et al. Aging Attenuates Cardiac Contractility and Affects Therapeutic Consequences for Myocardial Infarction. Aging Dis. 2020; 11 (2): 365-76. doi: 10.14336/AD.2019.0522
- Musso C.G., Oreopoulos D.G. Aging and physiological changes of the kidneys including changes in glomerular filtration rate. Nephron. Physiology. 2011; 119 (1): p1-p5. doi: 10.1159/000328010
- Rowland J., Akbarov A., Maan A. et al. Tick-Tock Chimes the Kidney Clock - from Biology of Renal Ageing to Clinical Applications. Kidney Blood Press Res. 2018; 43 (1): 55-67. doi: 10.1159/000486907
- Lala A., Desai A.S. The role of coronary artery disease in heart failure. Heart Fail Clin. 2014; 10 (2): 353-65. doi: 10.1016/j.hfc.2013.10.002
- Jin M., Qian Z., Yin J. et al. The role of intestinal microbiota in cardiovascular disease. J. Cell Mol Med. 2019; 23 (4): 2343-50. doi: 10.1111/jcmm.14195
- Куликова А.Н., Толстокоров А.С., Ларин И.В. Склероз Менкеберга: роль кальциноза в поражении артерий у больных сахарным диабетом. Ангиология и сосудистая хирургия. 2020; 26 (4): 17-21. doi: 10.33529/ANGI02020406
- Siontis G.C.M., Overtchouk P., Cahill T.J. et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart J. 2019; 40 (38): 3143-53. doi: 10.1093/eurheartj/ehz275
- Baumgartner H., Falk V., Bax J.J. et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38 (36): 2739-91. doi: 10.1093/eurheartj/ehx391
- Kumar R.K., Tandon R. Rheumatic fever & rheumatic heart disease: the last 50 years. Indian J. Med Res. 2013; 137 (4): 643-58.
- Hung L.C., Nadia R.A Review of Acute Rheumatic Fever and Rheumatic Heart Disease Research in Malaysia. Med J. Malaysia. 2016; 71 (1): 79-86.
- Alghamdi F., Chan M. Management of heart failure in the elderly. Curr Opin Cardiol. 2017; 32 (2): 217-23. doi: 10.1097/HTO.0000000000000375
- Skrzypek A., Mostowik M., Szeliga M. et al. Chronic heart failure in the elderly: still a current medical problem. Folia Medica Cracoviensia. 2018; 58 (4): 47-56.
- House A.A. Management of Heart Failure in Advancing CKD: Core Curriculum 2018. Am J. Kidney Dis. 2018; 72 (2): 284-95. doi: 10.1053/j.ajkd.2017.12.006
- Osmanska J., Jhund P.S. Contemporary Management of Heart Failure in the Elderly. Drugs Aging. 2019; 36 (2): 137-46. doi: 10.1007/s40266-018-0625-4
- Guder G., Stork S. COPD and heart failure: differential diagnosis and comorbidity. Herz. 2019; 44 (6): 502-8. doi: 10.1007/s00059-019-4814-7
- Pirina P., Zinellu E., Martinetti M. et al. COPD-HF Study Group. Treatment of COPD and COPD-heart failure comorbidity in primary care in different stages of the disease. Prim Health Care Res Dev. 2020; 5 (21): e16. doi: 10.1017/S1463423620000079
- Bomer N., Beverborg N.G., Hoes M.F. et al. Selenium and outcome in heart failure. Eur J. Heart Fail. 2020; 22 (8): 1415-23. doi: 10.1002/ejhf.1644
- Vaassen M.M. Manual Lymph Drainage in a Patient with Congestive Heart Failure: A Case Study. Ostomy Wound Manage. 2015; 61 (10): 38-45.
- Krysztofiak H., Wleklik M., Migaj J. et al. Cardiac Cachexia: A Well-Known but Challenging Complication of Heart Failure. Clin IntervAging. 2020; 15: 2041-51. doi: 10.2147/CIA.S273967
- Okoshi M.P., Capalbo R.V., Romeiro F.G. et al. Cardiac Cachexia: Perspectives for Prevention and Treatment. Arq Bras Cardiol. 2017; 108 (1): 74-80. doi: 10.5935/abc.20160142
- Zhang Z.H., Meng F.Q., Hou X.F. et al. Clinical characteristics and long-term prognosis of ischemic and non-ischemic cardiomyopathy. Indian Heart J. 2020; 72 (2): 93-100. doi: 10.1016/j.ihj.2020.04.004
- Cohn J.N. Unloading the failing heart. Previous experience and future directions. Am J. Hypertens. 1989; 2 (9): 736-739.
- Kobayashi M., Voors A.A., Girerd N. et al. Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF. Eur J. Intern Med. 2020; 71: 62-9. doi: 10.1016/j.ejim.2019.10.017
- Виноградова Н.Г., Поляков Д.С., Фомин И.В. и др. Прогноз жизни пациентов с хронической сердечной недостаточностью и фибрилляцией предсердий в зависимости от контроля гемодинамических показателей и толерантности к физической нагрузке на фоне базисной терапии. Кардиология. 2019; 59 (4S): 51-8. doi: 10.18087/cardio.2622